Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes
Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes

Glenmark pioneers Remogliflozin & Vildagliptin fixed dose for type 2 diabetes

Anthony Fernandes Article rating: 5.0

Glenmark Pharmaceuticals announced on Tuesday that it has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium-Glucose co-transporter inhibitors (SGLT2i)- Remogliflozin Etabonate and another commonly used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) – Vildagliptin, in India.  

Biocon Biologics to get Biologics licence application for cancer & eye disease medication
Biocon Biologics to get Biologics licence application for cancer & eye disease medication

Biocon Biologics to get Biologics licence application for cancer & eye disease medication

Shreya Chaware Article rating: 3.5

Biocon Biologics Ltd (a subsidiary of Biocon Ltd) and Mylan (a subsidiary of Viatris Inc.) have been further informed by United States Food & Drug Administration (USFDA) regarding the deferral of the action on Biologics licence application (BLA) for MYL-1402O, a proposed biosimilar to Avastin® (Bevacizumab). 

Fund your children education via MF investment
Fund your children education via MF investment

Fund your children education via MF investment

Shashikant Singh Article rating: 3.5

As your child takes baby steps and gradually climbs his/her education ladder, you have ample time and option to plan the funding in advance via education loan or mutual fund investment. Read this to find out which one is better and why! 

HDFC Life Insurance Company forms double bottom pattern
HDFC Life Insurance Company forms double bottom pattern

HDFC Life Insurance Company forms double bottom pattern

Vinayak Gangule Article rating: 3.4

On Monday, the stock had given a breakout above the neckline of a double bottom formation. This breakout is confirmed by the above 50-day average volume. Additionally, the stock had formed a sizeable bullish candle on the breakout day, which adds further strength to the breakout.

Coromandel International gives ascending triangle breakout
Coromandel International gives ascending triangle breakout

Coromandel International gives ascending triangle breakout

Vinayak Gangule Article rating: 3.5

The stock of Coromandel International has given an ascending triangle breakout on the daily timeframe. Further, the breakout is supported by a robust volume of more than 3 times of the 50-day average volume, indicating a strong buying interest by the market participants.

RSS
First25122513251425152517251925202521Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR